Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia
      QxMD      Google Scholar   
Citation:
Leukemia vol 31 (6) 1278-1285
Year:
2017
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
6
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Leuk Corr Sci
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA031946, U10CA033601, U10CA180821 and U10CA180882 (to the Alliance for Clinical Trials in Oncology), ; U10CA101140, U10CA180850, U10CA180867, CA077658, CA140158, CA016058, CA180821, CA180861, and CA196171, U10CA003927, U10CA031983, U10CA032291, U10CA035279, U10CA047545, P50 CA140158, U10 CA180861, U10 CA077658, U10 CA180821, U10 CA101140, U10 CA180882, U24 CA196171, P30 CA016058, R35 CA197734  
Corr. Author:
 
Authors:
                                       
Networks:
CT063, LAPS-AL002, LAPS-MA036, LAPS-OH007, MD015, NC002, NORTHWELL, OH070, PCRC   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-20202, CALGB-8461, CALGB-9665
Phases:
N/A
Keywords:
acute myeloid leukemia, core-binding factor, CCND1 , CCND2 , mutation